Introducing a molecular test into the clinical microbiology laboratory: Development, evaluation, and validation

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 9, 2003, Pages 1106-1111

  Forbes, Betty A ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ASSAY; CLINICAL LABORATORY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; LABORATORY TEST; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; STANDARD; VALIDATION PROCESS;

BACTERIA; BACTERIAL INFECTIONS; CLINICAL LABORATORY TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; VIRUS DISEASES; VIRUSES;

EID: 0041834447     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. Noordhoek GT, van Embden JDA, Kolk AH. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol. 1996;34:2522-2525.
2. Van Vliet KE, Muir P, Echevarria JM, Klapper PE, Cleator GM, van Loon AM. Multicenter proficiency testing of nucleic acid amplification methods for the detection of enteroviruses. J Clin Microbiol. 2001;39:3390-3392.
3. National Committee for Clinical Laboratory Standards. Molecular Diagnostic Methods for Infectious Diseases; Approved Guidelines. Wayne, Pa: NCCLS; 1993. NCCLS document MM3-A.
4. National Committee for Clinical Laboratory Standards. Quantitative Molecular Methods for Infectious Disease: Proposed Guidelines. Wayne, Pa: NCCLS; 2001. NCCLS document MM6-P.
5. McCreedy BJ, Callaway TH. Laboratory design and workflow. In: Persing DH, Smith TF, Tenover FC, et al, eds. Diagnostic Molecular Microbiology, Principles and Applications. Washington, DC: ASM Press; 1993.
6. McHutchinson JG, Gordon SC, Schiff ER, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis. N Engl J Med. 1999;339:1485-1492.
7. Schirm J, van Loon AM, Valentine-Thon E, et al. External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J Clin Microbiol. 2002;40:2973-2980.
8. Caliendo AM, St George K, Allega J, Bullotta AC, Gilbane L, Rinaldo CR. Distinguishing cytomegalovirus (CMV) infection and disease with CMV nucleic acid assays. J Clin Microbiol. 2002;40:1581-1586.
9. Aono T, Kono K, Miyoshi H, et al. Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification. J Infect Dis. 1998;178:1244-1249.
10. Palladino S, Pearman JW, Kay ID, et al. Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae genitourinary infections in males by the Amplicor PCR assay of urine. Diagn Microbiol Infect Dis. 1999;33:141-146.
11. Van Elden LJR, van Kraaij MGJ, Nijhuis M, et al. Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis. 2002;34:177-183.
12. Vuori-Holopainen E, Salo E, Saxén H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis. 2002;34:583-590.
13. Forbes BA, Hicks KE. Direct detection of Mycobacterium tuberculosis in respiratory specimens in a clinical laboratory using the polymerase chain reaction. J Clin Microbiol. 1993;31:1688-1694.
14. Forbes BA, Hicks KE. Substances interfering with direct detection of Mycobacterium tuberculosis in clinical specimens by PCR: effects of bovine serum albumin. J Clin Microbiol. 1996;34:2125-2128.
15. Williams F. Optimization strategies for the polymerase chain reaction. Biotechniques. 1989;7:762-768.
16. Markoulas P, Siafakas N, Moncany M. Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal. 2002;16:47-51.
17. Johnson JR. Development of polymerase chain reaction-based assays for bacterial gene detection. J Microbiol Methods. 2000;41:201-209.
18. Kirstein LM, Mellors JW, Rinaldo CR, et al. Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol. 1999;37:2428-2433.
19. Cook L, Ross AM, Knight GB, Agnello V. Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J Clin Microbiol. 2000;38:4326-4331.
20. Eisenach KE, Sifford MD, Cave MD, Bates JH, Crawford JT. Detection of Mycobacterium tuberculosis in sputum samples using a polymerase chain reaction. Am Rev Respir Dis. 1991;144:1160-1163.
21. Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB. Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J Clin Microbiol. 1998;36:3590-3594.
22. Wolk D, Mitchell S, Patel R. Principles of molecular biology testing methods. Infect Dis Clin North Am. 2001;15:1157-1204.
23. McGowan K. Diagnostic tests for pertussis: culture vs. DFA vs. PCR. Clin Microbiol Newsl. 2002;24:143-149.
24. Marcon MJ. Traditional and newer approaches to laboratory diagnosis of herpes simplex virus infections. Clin Microbiol Newsl. 1997;19:9-14.
25. van Doornum GJJ, Schouls LM, Pijl A, Cairo I, Buimer M, Bruisten S. Comparison between the LCx probe system and COBAS AMPLICOR system for detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in patients attending a clinic for treatment of sexually transmitted diseases in Amsterdam, the Netherlands. J Clin Microbiol. 2001;39:829-835.
26. van Dyck E, Ieven M, Pattyn S, van Damme L, Laga M. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol. 2001;39:1751-1756.
27. Morré SA, van Valkengoed IGM, Moes RM, Boeke AJP, Meijer CJLM, van den Brule AJC. Determination of Chlamydia trachomatis prevalence in an asymptomatic screening population: performances of the LCx and COBAS Amplicor tests in urine specimens. J Clin Microbiol. 1999;37:3092-3096.
28. Hadgu A. The discrepancy in discrepant analysis. Lancet. 1996;348:592-593.
29. Lakeman FD, Whitley RJ, and the National Institute of Allergy and Infectious Diseases Collaborative Study Group. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebral spinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis. 1995;171:857-863.
30. Farkkila M, Koskiniemi M, Vaheri A. Clinical spectrum of neurological herpes simplex infection. Acta Neurol Scand. 1993;34:625-627.
31. Coker NJ. Bell's palsy: a herpes simplex mononeuritis? Arch Otolaryngol Head Neck Surg. 1998;124:823-824.
32. Hardebo JE. An association between cluster headaches and herpes simplex. N Engl J Med. 1986;314:317.
33. Sureda B, Villalobos F, Gil-Neciga E, Martinez ML, Bautista J. Migraine and cerebral spinal fluid alterations: are they an expression of viral meningoencephalitis? Neurologia. 1987;2:54-56.
34. Neilsen PG. Recurrent HSV-1 virus infection complicated with recalcitrant headache treated with acyclovir. Acta Dermato-Venereol. 1992;72:236.
35. Peigue-Lafeuille H, Croquez N, Laurichesse H, et al. Enterovirus meningitis in adults in 1999-2000 and evaluation of clinical management. J Med Virol. 2002;67:47-53.
36. Dagan R, Shriker O, Hazan I, et al. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by OCR. J Clin Microbiol. 1998;36:669-673.
37. Studahl M, Hagberg L, Rekadbar E, Bergström T. Hematogenously spread herpesviruses are detected as frequently as neuronally spread herpesviruses in cerebral spinal fluid by polymerase chain reaction. Clin Infect Dis. 1999;29:216-217.
38. Jordan JA. Diagnosing human parvovirus B19 infection: guidelines for test selection. Mol Diagn. 2001;6:307-311.
39. Fredericks DN, Relman DA. Application of polymerase chain reaction to the diagnosis of infectious diseases. Clin Infect Dis. 1999;29:475-488.
40. Schirm J, van Loon AM, Valentine-Thom E, Klapper PE, Reid J, Cleator GM. External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J Clin Microbiol. 2002;40:2973-2980.
41. Noordhoek GT, van Embden JDA, Kolk AH. Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol. 1996;34:2522-2525.
42. Page B, Petrich A, Stevens D, et al. Training costs and investment payback of implementing molecular diagnostics for identification of vancomycin resistant enterococci in a clinical microbiology laboratory. Diagn Microbiol Infect Dis. 2002;42:91-97.
43. Nigrovic LE, Chang VW. Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis. Arch Pediatr Adolesc Med. 2000;154:817-821.
44. Hamilton MS, Jackson MA, Abel D. Clinical utility of polymerase chain reaction testing for enteroviral meningitis. Pediatr Infect Dis J. 1999;18:533-537.
45. Simko JP, Caliendo AM, Hogle K, Versalovic J. Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. Clin Infect Dis. 2002;35:414-419.
46. Greenberg M, Nassos P, Haller B. Evaluation of criteria for molecular diagnosis of herpes simplex virus central nervous system infections. American Society for Microbiology 102 General Meeting; May 22, 2002; Salt Lake City, Utah. Abstract C-230.